Evidence map›Paper›PMID 41890873›Full record

ReviewFrontiers in cardiovascular medicine2026

Summary of the best evidence for non-pharmacological interventions for dyslipidemia in patients with coronary heart disease.

Zhi Zeng, Xin Zhou, Li Jiang, Yuan Huang, Xiaochun He, Huaili Luo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhi Zeng *Department of Intensive Care Unit, Mianyang Central Hospital, Affiliated with the School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
Xin Zhou *Department of Gastroenterology, Mianyang Central Hospital, Affiliated with the School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
Li JiangDepartment of Cardiovascular Medicine, Mianyang Central Hospital, Affiliated with the School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
Yuan HuangDepartment of Cardiovascular Medicine, Mianyang Central Hospital, Affiliated with the School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
Xiaochun HeDepartment of Cardiovascular Medicine, Mianyang Central Hospital, Affiliated with the School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
Huaili LuoDepartment of Cardiovascular Medicine, Mianyang Central Hospital, Affiliated with the School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Retrieve, evaluate, and summarize evidence from domestic and international sources regarding non-pharmacological interventions for dyslipidemia in patients with coronary heart disease (CHD), providing reference for clinical practice. Methods: Following the "6S" evidence pyramid model, a systematic search was conducted for literature on non-pharmacological interventions for dyslipidemia in CHD patients, both domestically and internationally, covering the period from January 2014 to December 2025. Two researchers independently screened and evaluated the studies for inclusion, after which the evidence was synthesized. Results: A total of 31 studies were ultimately included, comprising 15 English-language publications and 16 Chinese-language publications. Thirty-one evidence points were summarized, covering seven evidence themes: multidisciplinary team formation, assessment, lipid-lowering targets, lifestyle modification, non-pharmacological traditional Chinese medicine (TCM) interventions, health education, and follow-up management. Conclusion: This study provides a comprehensive summary of the best available evidence on non-pharmacological interventions for dyslipidemia in patients with CHD. The findings can serve as a valuable reference for clinical practitioners, enabling healthcare professionals to develop personalized intervention plans based on the lipid profiles and specific needs of CHD patients.

Indexed as

dyslipidemianon-pharmacological interventionspatients with coronary heart diseasereviewsummary of the evidence

Identifiers

PMID41890873
PMCPMC13013076

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.